Literature DB >> 34411689

Advancedoral vaccine delivery strategies for improving the immunity.

Yuandong Zhang1, Man Li2, Guangsheng Du2, Xiaoyan Chen2, Xun Sun3.   

Abstract

Infectious diseases continue to inflict a high global disease burden. The consensus is that vaccination is the most effective option against infectious diseases. Oral vaccines have unique advantages in the prevention of global pandemics due to their ease of use, high compliance, low cost, and the ability to induce both systemic and mucosal immune responses. However, challenges of adapting vaccines for oral administration remain significant. Foremost among these are enzymatic and pH-dependent degradation of antigens in the stomach and intestines, the low permeability of mucus barrier, the nonspecific uptake of antigens at the intestinal mucosal site, and the immune suppression result from the elusive immune tolerance mechanisms. Innovative delivery techniques promise great potential for improving the flexibility and efficiency of oral vaccines. A better understanding of the delivery approaches and the immunological mechanisms of oral vaccine delivery systems may provide new scientific insight and tools for developing the next-generation oral vaccine. Here, an overview of the advanced technologies in the field of oral vaccination is proposed, including mucus-penetrating nanoparticle (NP), mucoadhesive delivery vehicles, targeting antigen-presenting cell (APC) nanocarriers and enhanced paracellular delivery strategies and so on. Meanwhile, the mechanisms of delivery vectors interact with mucosal barriers are discussed.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antigen-presenting cell; Gut-associated lymphoid tissue; Mucus; Oral vaccine; Targeted delivery system

Mesh:

Substances:

Year:  2021        PMID: 34411689     DOI: 10.1016/j.addr.2021.113928

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  4 in total

Review 1.  Mucosal vaccine delivery: A focus on the breakthrough of specific barriers.

Authors:  Mengwen Huang; Miaomiao Zhang; Hongbin Zhu; Xiaojiao Du; Jun Wang
Journal:  Acta Pharm Sin B       Date:  2022-07-06       Impact factor: 14.903

Review 2.  The Multi-Functional Roles of CCR7 in Human Immunology and as a Promising Therapeutic Target for Cancer Therapeutics.

Authors:  Faris Alrumaihi
Journal:  Front Mol Biosci       Date:  2022-07-06

Review 3.  Alginate: Enhancement Strategies for Advanced Applications.

Authors:  Alejandro Hurtado; Alaa A A Aljabali; Vijay Mishra; Murtaza M Tambuwala; Ángel Serrano-Aroca
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

4.  A SARS-CoV-2 oral vaccine development strategy based on the attenuated Salmonella type III secretion system.

Authors:  Leyang Wu; Lin Li; Xingpeng Yin; Chenyang Li; Wenjie Xin; Lina Liu; Zichun Hua
Journal:  J Appl Microbiol       Date:  2022-07-31       Impact factor: 4.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.